Atherid Breakthrough: Harry Perkins' CVD Drug | AcademicJobs AU
Explore the Atherid (ATH01) cardiovascular breakthrough at Harry Perkins Institute, affiliated with UWA and Curtin. This plaque-dissolving drug promises to transform heart disease treatment, highlighting Australia's research excellence.
research-publication-newscurtin-universitymedical-innovation

